
Is RMD (ResMed Inc.) Halal or Haram?
ResMed Inc. passes all AAOIFI Shariah screening criteria with exceptional financial purity. The company carries a minimal debt-to-market cap ratio of 2.7% and holds a cash and securities ratio of just 3.8%, both well below the 33% threshold. Additionally, its interest-bearing income is effectively 0.00%, making it a highly compliant option for Muslim investors.
Price Chart (5D)
RMD — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-05-01 | 206.00 | 206.84 | 198.64 | 205.02 | 3.2M | -0.48% |
| 2026-04-30 | 212.47 | 215.14 | 210.60 | 213.81 | 1.9M | +0.63% |
| 2026-04-29 | 215.68 | 216.59 | 211.93 | 211.93 | 1.3M | -1.74% |
| 2026-04-28 | 221.84 | 222.40 | 215.30 | 217.14 | 1.5M | -2.12% |
| 2026-04-27 | 219.13 | 223.92 | 218.86 | 222.02 | 1.3M | +1.32% |
| 2026-04-24 | 218.17 | 220.23 | 217.00 | 219.85 | 797K | +0.77% |
| 2026-04-23 | 221.38 | 221.47 | 216.68 | 219.51 | 987K | -0.84% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for RMD
Business Activity
Permissible
ResMed's core business of developing medical devices and cloud-based software for sleep and respiratory care is fully permissible and aligns with Islamic principles of promoting health.
Debt / Market Cap
2.69%
Interest Income
0.00%
Cash & Securities
3.82%
About ResMed Inc. (RMD)
ResMed Inc. is a global leader in digital health and cloud-connected medical devices, specializing in sleep apnea and respiratory care. The company manufactures ventilation devices, CPAP masks, and diagnostic products designed for both hospital and home use, alongside software solutions to manage patient outcomes.
For Muslim investors, ResMed represents a solid Halal investment opportunity, having passed all four AAOIFI screening criteria. Its core business of life-improving medical technology is fundamentally permissible, and it successfully meets all financial screening thresholds without issue, meaning investors can confidently add it to their portfolios.
From an Islamic finance perspective, ResMed boasts an exceptionally clean balance sheet. With a debt-to-market cap ratio of only 2.7% and zero reliance on interest income, the company operates well within Shariah boundaries, avoiding the excessive leverage that often disqualifies large healthcare firms.
Since there are no major scholarly debates regarding its core medical device business, investors can feel confident in its current compliance. However, Muslim shareholders should continue to monitor its cloud-based software segment for any future acquisitions that might introduce non-compliant revenue streams.
CEO
Michael J. Farrell
Employees
9,980
IPO Date
1995-06-02
Headquarters
San Diego, CA, US
Website
www.resmed.comRMD Key Financial Statistics
Revenue
$5.15B
Net Income
$1.40B
EPS (Diluted)
$9.51
Stock Price
217.14
Beta
0.93
52-Week Range
215.3-293.81
Total Debt
$851.8M
Total Equity
$5.97B
Current Ratio
3.44
RMD Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+9.8%
Prior year: $4.69B
Net Cash
$357.6M
Cash: $1.21B — Debt: $851.8M
R&D Spending
$331.3M
% of Revenue
6.4%
Frequently Asked Questions About RMD
Is RMD (ResMed Inc.) stock halal to invest in?▾
What does ResMed Inc. do?▾
What screening criteria were used for RMD?▾
Does RMD require income purification?▾
When was RMD last screened?▾
Disclaimer
This shariah compliance assessment for RMD (ResMed Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.